Evidence map›Paper›PMID 41840741›Full record

Observational studyBMJ open2026

Burden of atherosclerosis, cardiovascular risk factors and atrial fibrillation in individuals with covert brain infarcts in late midlife: the Akershus Cardiac Examination 1950 Study.

Håkon Ihle-Hansen, Marte M Walle-Hansen, Trygve Berge, Hege Ihle-Hansen, Peter Selmer Rønningen, Torbjørn Omland, Helge Røsjø, Arnljot Tveit, Mona Beyer, Kjetil Steine and 6 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01555411 (Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01555411 active not recruitingnot on this map

Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects

TypeobservationalSponsorVestre Viken Hospital TrustRan2012 to 2050Enrolled3,706ConditionsAtrial Fibrillation, Heart Failure, Mild Cognitive Impairment, Cardiovascular Diseases
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Håkon Ihle-HansenDepartment of Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway haaihl@vestreviken.no.ORCID http://orcid.org/0000-0001-7111-5970
Marte M Walle-HansenDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Trygve BergeDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Hege Ihle-HansenDepartment of Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Peter Selmer RønningenDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Torbjørn OmlandK.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.
Helge RøsjøK.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.
Arnljot TveitDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Mona BeyerInstitute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.
Kjetil SteineDepartment of Cardiology, Akershus Universitetssykehus HF, Lørenskog, Norway.
Magnus Nakrem LyngbakkenK.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.
Ole Morten RønningInstitute of Clinical Medicine, University of Oslo Faculty of Medicine, Oslo, Norway.
Thea VigenDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Terry QuinnSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Alan CameronSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0001-6965-1109
Guri HagbergDepartment of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.ORCID http://orcid.org/0000-0003-2822-7701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent expert consensus statements generally suggest cardiovascular risk assessment, including atrial fibrillation (AF) screening, on detection of covert brain infarctions (CBIs). However, evidence to guide management of CBI remains limited. In the absence of randomised clinical trials specifically targeting CBI populations, observational studies comparing individuals with and without CBI can provide insights into the prevalence and burden of cardiovascular risk factors.

objectivesWe aimed to compare the burden of atherosclerosis and cardiovascular risk factors in participants with CBI to those without, and to explore the yield of AF screening in individuals with CBI.

designA prospective population-based birth cohort study including men and women born in 1950 and resident in Akershus County, Norway.

settingThe two hospitals serving the population of Akershus county, Norway.

participantsParticipants included in the Akershus Cardiac Examination (ACE) 1950 study who also underwent a subsequent MRI examination were eligible for this study. OUTCOME MEASURES: Cardiovascular risk assessment was performed at study inclusion (2012-2015). Carotid ultrasound was used to quantify atherosclerosis through a carotid plaque score, and CHA₂DS₂-VA and Systematic COronary Risk Evaluation 2 (SCORE2) scores were calculated to estimate cardiovascular risk. Brain MRI was performed in a randomly selected, blood pressure-stratified subset of participants (2016-2024). CBI was defined as focal lesions consistent with ischaemia in the absence of clinical stroke. Participants with CBI were offered 72-hour ambulatory ECG monitoring for AF detection.

resultsMRI was performed in 414 of 3706 (11%) participants in the ACE 1950 Study. The mean age at the time of the MRI examination was 70.2±2.3 years, and 165 (41%) were women. CBI was identified in 54 participants (13%), of whom 45 (83%) completed 72-hour ambulatory ECG monitoring. There were no differences in mean carotid plaque score, SCORE2 or CHA₂DS₂-VA score between participants with CBI compared with those with normal MRI findings. AF was detected in one (2%) participant with CBI.

conclusionsIn this community-based cohort of individuals in late midlife, individuals with CBI did not have an increased cardiovascular risk compared with those without, as indicated by SCORE2, CHA₂DS₂-VA score, age-appropriate carotid plaque burden and a low prevalence of AF. TRIAL REGISTRATION NUMBER: URL: https://www. CLINICALTRIALS: gov. Unique identifier: NCT01555411.

Indexed as

AtherosclerosisAtrial FibrillationBrain InfarctionAgedFemaleHeart Disease Risk FactorsHumansMagnetic Resonance ImagingMaleMiddle AgedNorwayPrevalenceProspective StudiesRisk AssessmentRisk FactorsUltrasonography, Carotid ArteriesCross-Sectional StudiesEPIDEMIOLOGYRisk FactorsSTROKE MEDICINE

Identifiers

PMID41840741
PMCPMC12993315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.